Home> Products> extended release formulations

{ "products": [ { "_id": "66643724db9fdd21801f1af0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 800 ER ", "description": "MESALMILE 800 ER \nMesalamine (800mg)\nMESALMILE 800 ER is a medication that contains Mesalamine in an extended-release (ER) formulation, with each tablet containing 800mg of Mesalamine. Mesalamine belongs to a class of medications known as aminosalicylates, which are used to treat various inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.\n\nMesalamine works by reducing inflammation in the colon and rectum. It is believed to inhibit the production of inflammatory chemicals in the body, thus helping to alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding that are common in inflammatory bowel diseases.\n\nThe extended-release formulation of MESALMILE 800 ER allows for a gradual release of Mesalamine throughout the day, providing sustained relief from symptoms and reducing the frequency of dosing compared to immediate-release formulations.\n\nIt is important to take MESALMILE 800 ER as prescribed by your healthcare provider. Dosage and duration of treatment may vary depending on the severity of your condition and your individual response to the medication. Regular monitoring and follow-up with your healthcare provider are essential to ensure the effectiveness and safety of treatment.\n\nCommon side effects of Mesalamine may include nausea, vomiting, diarrhea, abdominal pain, and headache. Serious side effects such as allergic reactions or worsening of symptoms should be reported to your healthcare provider immediately.\n\nMESALMILE 800 ER is a valuable medication for managing inflammatory bowel diseases, but it should be used under the guidance and supervision of a healthcare professional to optimize its benefits and minimize potential risks.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mesalmile-800-er-133781\n\n\n\n\n\n\n", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Call", "ORDER", "Email", "colon", "Crohn", "class", "800mg", "dosing", "tablet", "Dosage", "safety", "rectum", "nausea", "symptoms", "severity", "diarrhea", "duration", "vomiting", "WhatsApp", "headache", "guidance", "benefits", "follow-up", "frequency", "treatment", "worsening", "condition", "production", "Mesalamine", "information", "supervision", "medications", "sterispharma", "sterisonline", "inflammation", "effectiveness", "abdominal pain", "rectal bleeding", "potential risks", "gradual release", "aminosalicylates", "sustained relief", "MESALMILE 800 ER", "allergic reactions", "ulcerative colitis", "Regular monitoring", "individual response", "healthcare provider", "valuable medication", "Common side effects", "Serious side effects", "inflammatory chemicals", "healthcare professional", "extended-release formulation", "immediate-release formulations", "extended-release (ER) formulation", "various inflammatory bowel diseases" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1578, "imageuri": "https://productimages.withfloats.com/actual/66643727cb17fd7b0aaa1e3d.png", "tileimageuri": "https://productimages.withfloats.com/tile/66643727cb17fd7b0aaa1e3d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:49:08.066Z", "updatedon": "2024-06-28T09:18:38.816Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mesalmile-800-er-/1578", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MESALMILE 800 ER ", "category": "GASTROLOGYRANGE", "tags": [ "MESALMILE 800 ER", "Mesalamine 800mg uses", "Mesalamine (800mg)", "Mesalamine 800mg dosage", "Mesalamine 800mg side effects", "Mesalamine 800mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666435a84515df17486247f1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 400", "description": "MESALMILE 400\nMesalamine ER (400mg)\nMESALMILE 400 is a medication containing Mesalamine ER (extended-release) in a 400mg dosage. Mesalamine is a type of anti-inflammatory drug used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. The extended-release formulation ensures a gradual and sustained release of the medication, providing consistent therapeutic effects.\n\nMesalamine works by reducing inflammation in the digestive tract, specifically targeting the lining of the colon. It helps to alleviate symptoms such as abdominal pain, diarrhea, rectal bleeding, and urgency to have a bowel movement, which are common in ulcerative colitis and Crohn's disease.\n\nThe extended-release formulation of Mesalamine allows for less frequent dosing, often once daily, compared to immediate-release formulations that may require multiple doses throughout the day. This convenience can improve medication adherence and patient compliance.\n\nIt is important to follow the prescribed dosage and administration instructions provided by your healthcare provider when using MESALMILE 400. Regular monitoring and follow-up appointments may be necessary to assess the effectiveness of the medication and manage any potential side effects.\n\nCommon side effects of Mesalamine may include nausea, vomiting, diarrhea, abdominal pain, headache, and rash. Serious side effects such as allergic reactions or worsening of certain conditions may occur but are rare. It is essential to report any unusual or severe symptoms to your healthcare provider promptly.\n\nMESALMILE 400 with Mesalamine ER (400mg) is an effective medication for managing inflammatory bowel diseases and improving the quality of life for patients experiencing symptoms related to these conditions.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mesalmile-400-133779\n\n\n\n\n\n\n", "price": 88.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IBD", "day", "life", "rash", "type", "ORDER", "Crohn", "Email", "colon", "lining", "nausea", "gradual", "quality", "unusual", "urgency", "diarrhea", "vomiting", "headache", "patients", "WhatsApp", "worsening", "MESALMILE", "conditions", "information", "convenience", "inflammation", "sterispharma", "sterisonline", "400mg dosage", "Mesalamine ER", "effectiveness", "multiple doses", "bowel movement", "abdominal pain", "digestive tract", "rectal bleeding", "severe symptoms", "sustained release", "patient compliance", "Regular monitoring", "allergic reactions", "ulcerative colitis", "healthcare provider", "Common side effects", "less frequent dosing", "medication adherence", "effective medication", "Serious side effects", "potential side effects", "follow-up appointments", "anti-inflammatory drug", "administration instructions", "inflammatory bowel diseases", "extended-release formulation", "immediate-release formulations", "consistent therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1576, "imageuri": "https://productimages.withfloats.com/actual/667d3a09c134db5b38ba7e15.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3a09c134db5b38ba7e15.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:42:48.751Z", "updatedon": "2024-06-28T09:20:38.747Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mesalmile-400/1576", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MESALMILE 400", "category": "GASTROLOGYRANGE", "tags": [ "MESALMILE 400 mg price", "Mesalamine ER (400mg)", "Mesalamine dosage for ulcerative colitis", "Mesalamine side effects", "mesalamine 1.2gm tablets", "mesalamine 1.2gm dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66642af22bed1f08484d8342", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " LANSOSTRUM 60", "description": "LANSOSTRUM 60\nDexlansoprazole (MR) (60mg)\nLansostrum 60 contains Dexlansoprazole (MR) in a strength of 60mg. Dexlansoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It is commonly prescribed to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and stomach ulcers.\n\nDexlansoprazole (MR) differs from traditional dexlansoprazole formulations in that it is designed to provide extended-release action, maintaining acid suppression over a longer period compared to immediate-release formulations. This extended-release feature allows for once-daily dosing convenience.\n\nLansostrum 60, with Dexlansoprazole (MR) 60mg, helps relieve symptoms such as heartburn, regurgitation, and indigestion associated with GERD. It helps heal and prevent damage to the esophagus caused by stomach acid.\n\nIt's important to take Lansostrum 60 as directed by your healthcare provider. Common side effects may include headache, diarrhea, abdominal pain, and nausea. Serious side effects such as severe allergic reactions or Clostridium difficile-associated diarrhea (CDAD) are rare but should be reported to your doctor immediately if experienced.\n\nAs with any medication, discuss with your doctor about your medical history, other medications you are taking, and any allergies before starting Lansostrum 60 to ensure it is safe and appropriate for .\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/lansostrum-60-133773", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PPI", "60mg", "Call", "GERD", "CDAD", "ORDER", "Email", "doctor", "nausea", "damage", "amount", "headache", "strength", "WhatsApp", "symptoms", "allergies", "heartburn", "esophagus", "conditions", "LANSOSTRUM", "information", "indigestion", "sterispharma", "sterisonline", "stomach acid", "regurgitation", "longer period", "stomach ulcers", "abdominal pain", "medical history", "acid suppression", "other medications", "healthcare provider", "Common side effects", "Dexlansoprazole (MR", "erosive esophagitis", "Serious side effects", "proton pump inhibitor", "extended-release action", "extended-release feature", "daily dosing convenience", "severe allergic reactions", "immediate-release formulations", "gastroesophageal reflux disease", "traditional dexlansoprazole formulations", "Clostridium difficile-associated diarrhea" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1569, "imageuri": "https://productimages.withfloats.com/actual/66642af51a59977b77dffe1c.png", "tileimageuri": "https://productimages.withfloats.com/tile/66642af51a59977b77dffe1c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T09:57:06.613Z", "updatedon": "2024-06-28T09:31:27.591Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/-lansostrum-60/1569", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": " LANSOSTRUM 60", "category": "GASTROLOGYRANGE", "tags": [ "LANSOSTRUM 60", "Dexlansoprazole (MR) (60mg)", "Dexlansoprazole side effects", "Dexlansoprazole 60 mg uses", "Dexlansoprazole 60 mg price", "Dexlansoprazole vs omeprazole" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661af452bed1f08484d625b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 30 ", "description": "TRIGLICLAGLAZE 30 \nGliclazide (SR) Pioglitazone and Metformin HCL (SR)\nTRIGLICLAGLAZE 30 is a combination medication formulated to manage type 2 diabetes mellitus effectively. It combines three key components: Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), each targeting different aspects of glucose regulation to achieve optimal blood sugar control.\n\nGliclazide (SR): Gliclazide is a sulfonylurea medication that works by stimulating the pancreas to release insulin, which helps lower blood sugar levels. The sustained-release (SR) formulation ensures a gradual and prolonged release of the medication, providing consistent glucose-lowering effects throughout the day.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of drugs and enhances insulin sensitivity in muscle and fat tissues. By improving the body's response to insulin, Pioglitazone helps reduce insulin resistance and promotes better glucose utilization by cells.\n\nMetformin HCI (SR): Metformin is a biguanide medication that works primarily by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects and providing extended blood sugar control.\n\nKey Benefits of TRIGLICLAGLAZE 30:\nComprehensive Glucose Control: The combination of Gliclazide (SR), Pioglitazone, and Metformin HCI (SR) targets multiple pathways involved in glucose metabolism. This comprehensive approach helps achieve better overall blood sugar control throughout the day.\n\nStimulates Insulin Release: Gliclazide stimulates insulin secretion from the pancreas, especially after meals, which is crucial for managing postprandial (after-meal) glucose spikes.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in muscle and fat tissues, allowing for better glucose uptake and utilization by cells. This action helps reduce insulin resistance, a hallmark of type 2 diabetes.\n\nReduces Hepatic Glucose Production: Metformin HCI (SR) reduces the production of glucose in the liver, helping to lower fasting blood sugar levels and prevent excessive glucose release into the bloodstream.\n\nExtended Blood Sugar Control: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, leading to consistent blood sugar control and minimizing the risk of hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) fluctuations.\n\nDosage and Administration:\nTRIGLICLAGLAZE 30 is typically taken orally once or twice daily, as prescribed by a healthcare provider.\nThe medication is often taken with meals to reduce the risk of gastrointestinal side effects.\nDosage adjustments may be necessary based on blood sugar levels and individual response to treatment. Follow your doctor's instructions carefully.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-30-134278", "price": 125.0, "discountamount": 37.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "risk", "drugs", "meals", "Order", "liver", "cells", "EMAIL", "doctor", "muscle", "action", "pancreas", "hallmark", "treatment", "Gliclazide", "fat tissues", "information", "medications", "bloodstream", "Pioglitazone", "sterisonline", "postprandial", "hypoglycemia", "fluctuations", "instructions", "sterispharma", "Key Benefits", "hyperglycemia", "CALL/WHATSAPP", "Metformin HCL", "Metformin HCI", "glucose uptake", "Administration", "TRIGLICLAGLAZE", "low blood sugar", "gradual release", "Insulin Release", "high blood sugar", "prolonged release", "insulin secretion", "different aspects", "multiple pathways", "peripheral tissues", "insulin resistance", "Dosage adjustments", "blood sugar levels", "glucose metabolism", "glucose regulation", "glucose utilization", "individual response", "insulin sensitivity", "healthcare provider", "meal) glucose spikes", "three key components", "biguanide medication", "combination medication", "comprehensive approach", "thiazolidinedione class", "sulfonylurea medication", "type 2 diabetes mellitus", "excessive glucose release", "Hepatic Glucose Production", "overall blood sugar control", "optimal blood sugar control", "extended blood sugar control", "gastrointestinal side effects", "sustained-release formulation", "Comprehensive Glucose Control", "consistent blood sugar control", "sustained-release (SR) formulation", "consistent glucose-lowering effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1484, "imageuri": "https://productimages.withfloats.com/actual/6661af49f21358d53af3ccec.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661af49f21358d53af3ccec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:44:53.071Z", "updatedon": "2024-06-28T12:15:14.626Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-30-/1484", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIGLICLAGLAZE 30 ", "category": "DIABETIC RANGE", "tags": [ "TRIGLICLAGLAZE 30", "Gliclazide (SR)", "Pioglitazone", "Metformin HCL (SR)", "Metformin SR 500mg uses", "Metformin hydrochloride 500 mg", "Metformin SR 500 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66602642dce9381dfcc57613", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PRAZOPRIME XL 5", "description": "PRAZOPRIME XL 5\nPrazosin SR 5.0\nPRAZOPRIME XL 5 is a potent medication formulated with Prazosin SR 5.0, designed to manage hypertension effectively. Prazosin SR 5.0, a sustained-release formulation, ensures consistent blood pressure control throughout the day.\n\nThis medication works by relaxing blood vessels, allowing blood to flow more smoothly, thus reducing the workload on the heart and lowering blood pressure. It is commonly prescribed for patients with hypertension, a condition that can lead to serious health complications if left unmanaged.\n\nThe extended-release nature of Prazosin SR 5.0 in PRAZOPRIME XL 5 provides convenience by requiring fewer daily doses compared to immediate-release formulations. This helps improve medication adherence and enhances treatment outcomes.\n\nPatients using PRAZOPRIME XL 5 should follow their healthcare provider's instructions regarding dosage and administration. Regular monitoring of blood pressure and periodic check-ups are essential for optimal management of hypertension.\n\nLike all medications, PRAZOPRIME XL 5 may have potential side effects such as dizziness, fatigue, and low blood pressure. It is crucial to report any unusual symptoms to your doctor promptly.\n\nConsult your healthcare provider to determine if PRAZOPRIME XL 5 is suitable for your hypertension management needs.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/prazoprime-xl-5-134147\n\n\n\n\n\n\n", "price": 275.0, "discountamount": 83.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Call", "heart", "Email", "dosage", "doctor", "product", "fatigue", "WhatsApp", "patients", "workload", "condition", "dizziness", "Prazosin SR", "medications", "information", "convenience", "instructions", "sterisonline", "sterispharma", "blood vessels", "PRAZOPRIME XL", "administration", "unusual symptoms", "fewer daily doses", "potent medication", "low blood pressure", "Regular monitoring", "treatment outcomes", "optimal management", "periodic check-ups", "healthcare provider", "medication adherence", "potential side effects", "extended-release nature", "serious health complications", "sustained-release formulation", "hypertension management needs", "immediate-release formulations", "consistent blood pressure control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1351, "imageuri": "https://productimages.withfloats.com/actual/666026464b2b24fcd89ab870.png", "tileimageuri": "https://productimages.withfloats.com/tile/666026464b2b24fcd89ab870.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T08:48:02.694Z", "updatedon": "2024-06-29T12:47:41.555Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/prazoprime-xl-5/1351", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PRAZOPRIME XL 5", "category": "CARDIOLOGYRANGE", "tags": [ "PRAZOPRIME XL 5", "Prazosin SR 5.0", "Prazopress XL 5 uses", "Prazopress XL 5 side effects", "Prazopress XL 5 Uses in Hindi", "Prazopress XL 5 generic Name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6634d7914194481fc81fe482", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CBENZPRIME ER 30 ", "description": "CBENZPRIME ER 30 \nCyclobenzaprine HCI (ER30mg)\nCBENZPRIME ER 30 is a medication that contains Cyclobenzaprine HCI in an extended-release (ER) formulation with a strength of 30mg per dose. Cyclobenzaprine HCI is a muscle relaxant used to treat muscle spasms and discomfort caused by musculoskeletal conditions like strains, sprains, and injuries.\n\nIts extended-release formulation means that the medication is designed to release the drug slowly over time, providing a longer duration of action compared to immediate-release formulations. This can result in sustained relief from muscle spasms and associated pain throughout the day, allowing for improved functionality and comfort for individuals dealing with muscle-related issues.\n\nIt's essential to follow the prescribed dosage and instructions provided by your healthcare provider for safe and effective use of CBENZPRIME ER 30. Always consult your doctor before starting or changing any medication regimen.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n", "price": 239.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "time", "drug", "dose", "safe", "ER30mg", "dosage", "action", "doctor", "sprains", "strains", "strength", "injuries", "discomfort", "individuals", "instructions", "effective use", "functionality", "CBENZPRIME ER", "muscle spasms", "associated pain", "longer duration", "muscle relaxant", "sustained relief", "medication regimen", "Cyclobenzaprine HCI", "healthcare provider", "muscle-related issues", "musculoskeletal conditions", "extended-release formulation", "immediate-release formulations", "extended-release (ER) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1064, "imageuri": "https://productimages.withfloats.com/actual/6634d7d4c76b7398ff8717af.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6634d7d4c76b7398ff8717af.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-03T12:24:49.193Z", "updatedon": "2024-06-12T11:07:39.922Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cbenzprime-er-30-/1064", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cyclobenzaprine HCI (ER30mg)", "category": "ORTHOLOGYRANG", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b0256b813270ffac595cb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.", "price": 550.0, "discountamount": 165.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2166, "imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:46:19.602Z", "updatedon": "2025-08-28T09:46:19.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 100 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6842b8014256f7114dfbd884", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "Trelagliptin 100mg in TRELAQWK 100 is an innovative once-weekly oral medication formulated with Trelagliptin 100mg, specifically designed to support adults in managing type 2 diabetes mellitus (T2DM). As a member of the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class, it provides a simplified and effective approach to improving glycemic control when combined with a healthy diet and regular exercise. Its weekly dosing schedule enhances treatment adherence, offering a more sustainable option for long-term diabetes care.\n\nActive Ingredient:\nTrelagliptin 100mg\nA potent, long-acting DPP-4 inhibitor that helps maintain stable blood glucose levels by preserving incretin activity. Incretins are natural hormones that promote insulin release and suppress glucagon, playing a vital role in blood sugar regulation.\n\nCore Benefits:\nConvenient once-weekly dosing enhances patient compliance\n\nEffectively lowers both fasting and postprandial (after-meal) blood sugar\n\nPromotes natural insulin production without contributing to weight gain\n\nCarries a low risk of hypoglycemia, especially when not used with insulin\n\nCan be used alone or in combination with other antidiabetic medications like metformin or sulfonylureas\n\nMechanism of Action:\nTRELAQWK 100 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These hormones play a crucial role in regulating blood sugar after meals. By prolonging their activity, Trelagliptin enhances insulin secretion and reduces glucagon levels, resulting in improved glycemic control. Its extended half-life allows for once-a-week administration, setting it apart from daily DPP-4 inhibitors.\n\nDosage & Administration:\nRecommended Dose: One tablet per week, or as advised by your doctor\n\nHow to Take: With or without food, preferably on the same day each week\n\nIf a dose is missed, do not double the next dose; seek guidance from your healthcare provider\n\nPossible Side Effects:\nTRELAQWK 100 is generally safe and well-tolerated. Some individuals may experience:\n\nHeadache\n\nNasopharyngitis (mild cold symptoms)\n\nConstipation\n\nUpper respiratory tract infections\n\nRare allergic reactions such as rashes or skin irritation\n\nSeek immediate medical advice if you experience unusual symptoms such as severe abdominal pain, persistent skin reactions, or signs of pancreatitis.", "price": 3.0, "discountamount": 1.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medical advice", "generally safe", "healthcare provider", "food preferably", "extended halflife", "crucial role", "dpp4 enzyme", "sulfonylureas mechanism", "antidiabetic medications", "low risk", "vital role", "sustainable option", "regular exercise", "healthy diet", "effective approach", "support adults", "trelaqwk 100trelaqwk 100", "hormones play", "natural hormones", "dose seek guidance", "promote insulin release", "degrades incretin hormones", "experience unusual symptoms", "skin irritation seek", "onceaweek administration setting", "improved glycemic control", "regulating blood sugar", "weight gain carries", "suppress glucagon playing", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2132, "imageuri": "https://productimages.withfloats.com/actual/6842b80c8a53ae8db15a02ac.png", "tileimageuri": "https://productimages.withfloats.com/tile/6842b80c8a53ae8db15a02ac.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-06T09:42:25.371Z", "updatedon": "2025-06-11T11:17:09.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2132", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Trelagliptin 100mg", "category": "DIABETIC RANGE", "tags": [ "Trelagliptin side effects", "Trelagliptin brand name", "Trelagliptin brands in India", "Trelagliptin uses", "Trelagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }